Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
European Pharmaceutical Journal
Volume 64 (2017): Issue 1 (September 2017)
Open Access
Combination treatment with valsartan and amlodipine intensifies evening suppression of Bmal1 clock gene in kidneys of spontaneously hypertensive rats
P. Potucek
P. Potucek
,
M. Radik
M. Radik
,
G. Doka
G. Doka
,
E. Kralova
E. Kralova
,
P. Krenek
P. Krenek
and
J. Klimas
J. Klimas
| Nov 10, 2017
European Pharmaceutical Journal
Volume 64 (2017): Issue 1 (September 2017)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Nov 10, 2017
Page range:
22 - 25
Received:
Mar 16, 2017
Accepted:
May 12, 2017
DOI:
https://doi.org/10.1515/afpuc-2017-0008
Keywords
Chronotherapy
,
valsartan
,
amlodipine
,
spontaneously hypertensive rats (SHR)
,
Bmal1
,
clock genes
© 2017 Potucek P. et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
P. Potucek
Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmacology and Toxicology
Bratislava
M. Radik
Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmacology and Toxicology
Bratislava
G. Doka
Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmacology and Toxicology
Bratislava
E. Kralova
Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmacology and Toxicology
Bratislava
P. Krenek
Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmacology and Toxicology
Bratislava
J. Klimas
Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmacology and Toxicology
Bratislava